torna alla home

DIARREA CRONICA – MALASSORBIMENTO DEGLI ACIDI BILIARI

BIBLIOGRAFIA

  1. Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut 2018; 67: 1380-99.
  2. Baena García A, Partida Palma F, García Martínez S, et al. (75) Se-Homocholic acid taurine scintigraphy 75SeHCAT, a standard benchmark test in bile acid malabsorption? Rev Esp Med Nucl Imagen Mol 2019; 38:305-11.
  3. Bannaga A, Kelman L, O’Connor M, Pitchford C, Walters JR, Arasaradnam RP. How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomes. BMJ Open Gastroenterol 2017; 4: e000116.
  4. Barkun AN, Love J, Gould M, Henryk Pluta, Hillary Steinhart. Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment. Can J Gastroenterol 2013;27: 653-9.
  5. Berti G, Rettura F, Lambiase C, Bellini M. Empirical trial or diagnostic tests for bile acid diarrhea? That is the question! J Dig Dis. 2021 Sep;22(9):557-558. doi: 10.1111/1751-2980.13044. Epub 2021 Sep 1. PMID: 34415680 No abstract available.
  6. Borghede MK, Schlutter JM, Agnholt JS, Christensen LA, Gormsen LC, Dahlerup JF. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75) SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea. Eur J Intern Med 2011; 22: e137–e140.
  7. Brydon WG, Culbert P, Kingstone K, et al. An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea. Can J Gastroenterol 2011; 25: 319-23.
  8. Camilleri M. Bile Acid Diarrhea: Prevalence, Pathogenesis, and Therapy. Gut and Liver, Vol. 9, No. 3, May 2015, pp. 332-9.
  9. Camilleri M. Dissecting Molecular Mechanisms in Bile Acid Diarrhea. Am J Gastroenterol 2016; 111: 433-5.
  10. Camilleri M, Vijayvargiya P. The role of Bile Acids in Chronic Diarrhea. Am J Gastroenterol 2020; 115: 1596-1603.
  11. Chunxia C, Jingjing J, Rui S, et al. Downregulation of Serum and Distal Ileum Fibroblast Growth Factor19 in Bile Acid Diarrhoea Patients. Dig Dis and Sciences 2022; 67:872-879.
  12. Covington JA, Westenbrink EW, Ouaret N, et al. Application of a novel tool for diagnosing bile acid diarrhoea. Sensors (Basel) 2013; 13: 11899-912.
  13. Drossman DA, Chang L, Chey WD, Kellow J, Tack J, Whitehead WE, eds. Functional Gastrointestinal Disorders. Disorders of Brain-gut Interaction. Volume 1. 4th ed. Raleigh, N.C.: Rome Foundation, 2016:1-32.
  14. Fani B, Bertani L, Paglianiti I, et al. Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique. Gastroenterol Res Pract 2018; 2097359.
  15. Fernandes DCR, Poon D, White LL, Andreyev HJN. What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea? Frontline Gastroenterol 2019; 10:72-7.
  16. Fernandez-Bañares F, Esteve M, Salas A, et al. Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci 2001; 46:2231-8.
  17. Fernández-Bañares F, Esteve M, Salas A, et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol 2007;102: 2520-8.
  18. Ford G, Preece J, Davies I, et al. Use of the SeHCAT test in the investigation of diarrhoea. Br Med J 1992; 68: 272.
  19. Goodwin B, Jones SA, Price RR, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000; 6: 517-26.
  20. Gracie D, Kane J, Mumtaz S, et al. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil 2012; 24: 983– e538.
  21. Gracie DJ, Kane JS, Mumtaz S, Scarsbrook AF, Chowdhury FU, Ford AC. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil 2012; 24:983-e538.
  22. Hofmann AF. Chronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last. Expert Rev Gastroenterol Hepatol 2009;3:461-4.
  23. Hofmann AF. The syndrome of ileal disease and the broken enterohepatic circulation: cholerheic enteropathy. Gastroenterology 1967; 52: 752-7.
  24. Inagaki T, Choi M, Moschetta A, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005; 2: 217-25.
  25. Johnston I, Nolan J, Pattni SS, Walters JR. New insights into bile acid malabsorption. Curr Gastroenterol Rep 2011;13:418-25.
  26. Kim I, Ahn SH, Inagaki T, et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 2007; 48: 2664-72.
  27. Koga T, Nishida T, Miwa H, et al. Effects of dietary butter fat on fecal bile acid excretion in patients with Crohn’s disease on elemental diet. Dig Dis Sci 1984; 29: 994-9.
  28. Kong B, Wang L, Chiang JY, Zhang Y, Klaassen CD, Guo GL. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology 2012; 56: 1034-43.
  29. Kurien M, Evans KE, Leeds JS, et al. Bile acid malabsorption: an under‐investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms. Scand J Gastroenterol 2011; 1–5.
  30. Kurien M, Thurgar E, Davies A, Akehurst R, Andreyev J. Challenging current views on bile acid diarrhoea and malabsorption. Frontline gastroenterology 2018; 9: 92-7.
  31. Lim SJ, Gracie DJ, Kane JS, et al., Prevalence of, and predictors of, bile acid diarrhea in outpatients with chronic diarrhea: A follow-up study. Neurogastroenterol Motil 2019; 31: e13666.
  32. Lyutakov I, Ursini F, Penchev P, et al. Methods for diagnosing bile acid malabsorption: a systematic review. BMC Gastroenterol 2019;19: 185.
  33. Makishima M, Okamoto AY, Repa JJ, et al. Identification of a nuclear receptor for bile acids. Science 1999; 284: 1362-5.
  34. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology 2016; 150: 1393-1407.
  35. Mena Bares LM, Carmona Asenjo E, García Sánchez MV, et al. 75SeHCAT scan in bile acid malabsorption in chronic diarrhoea. Rev Esp Med Nucl Imagen Mol 2017;36: 37-47.
  36. Merrick MV, Eastwood MA, Ford MJ. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. BMJ 1985; 290:665–8.
  37. Mottacki N, Simrén M, Bajor A. Review article: bile acid diarrhoea – pathogenesis, diagnosis and management. Aliment Pharmacol Ther 2016; 43:884-98.
  38. Murray IA, Murray LK, Woolson KL at al. Incidence and predictive factors for positive 75SeHCAT test: improving the diagnosis of bile acid diarrhoea. Scand J Gastroent 2017
  39. Notghi A, O’Brien J, Low CS, Thomson W. Measuring SeHCAT retention: a technical note. Nucl Med Commun 2011; 32:960-6.
  40. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol 2010; 8:159-65.
  41. Pattni S, Walters JR. Recent advances in the understanding of bile acid malabsorption. Br Med Bull 2009;92:79-93.
  42. Pattni SS, Brydon WG, Dew T, Walters JR. Fibroblast Growth Fac- tor 19 and 7a-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea. Clin Transl Gastroenterol 2012; 3:e18.
  43. Riemsma R, Al M, Corro Ramos I, et al. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis. Health Technol Assess 2013; 17:1–236.
  44. Ruiz-Campos L, Gisbert JP, Ysamat M, et al. Systematic review with meta-analysis: the prevalence of bile acid malabsorption and response to colestyramine in patients with chronic watery diarrhoea and previous cholecystectomy. Aliment Pharmacol Ther 2019; 49:242-50.
  45. Sadowski DC, Camilleri M, Chey WD, et al. Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea. J Can Assoc Gastroenterol 2020; 3: e10-e27.
  46. Sali A, Murray WR, MacKay C. Aluminium hydroxide in bile-salt diarrhoea. Lancet 1977; 2:1051-3.
  47. Sauter GH, Münzing W, von Ritter C, Paumgartner G. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig Dis Sci 1999; 44:14-9.
  48. Sayin SI, Wahlstrom A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013; 17: 225-35.
  49. Slattery SA, Niaz O, Aziz Q, Ford AC, Farmer AD. Systematic re- view with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther 2015; 42:3-11.
  50. Summers JA, Peacock J, Coker B, et al. Multicentre prospective survey of SeHCAT provision and practice in the UK. BMJ Open Gastro 2016;3: e000091.
  51. Turner JM, Pattni SS, Appleby RN, Walters JR. A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea. Frontline Gastroenterol 2017; 8:279-83.
  52. Ung KA, Gillberg R, Kilander A, Abrahamsson H. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 2000;46:170-5.
  53. Valdés Olmos R, den Hartog Jager F, Hoefnagel C, Taal B. Effect of loperamide and delay of bowel motility on bile acid malabsorption caused by late radiation damage and ileal resection. Eur J Nucl Med 1991;18:346-50.
  54. Valentin N, Camilleri M, Altayar O, et al. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis. Gut 2016;65: 1951–9.
  55. Vijayvargiya P, Camilleri M, Carlson P, et al. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther 2017; 46:581-8.
  56. Vijayvargiya P, Camilleri M, Shin A, Saenger A. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol 2013; 11: 1232-9
  57. Vijayvargiya P, Camilleri M. Current Practice in the Diagnosis of Bile Acid Diarrhea. Gastroenterology 2019; 156:1233-8.
  58. Vijayvargiya P, Camilleri M. Update on Bile Acid Malabsorption: Finally Ready for Prime Time? Curr Gastroenterol Rep 2018;20: 10.
  59. Walters JR, Johnston IM, Nolan JD, Vassie C, Pruzanski ME, Shapiro DA. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid. Aliment Pharmacol Ther 2015;41: 54-64.
  60. Walters JR, Pattni SS. Managing bile acid diarrhoea. Therap Adv Gastroenterol 2010; 3: 349-57.
  61. Walters JR. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder. Expert Rev Gastroenterol Hepatol 2010; 4:561-7.
  62. Wedlake L, A’Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009; 30:707-17.
  63. Wedlake L, Thomas K, Lalji A, Anagnostopoulos C, Andreyev HJ. Effectiveness and tolerability of colesevelam hydrochloride for bile acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire. Clin Ther 2009; 31:2549-58.
  64. Wilcox C, Turner J, Green J. Systematic review: the management of chronic diarrhoea due to bile acid malabsorption. Alim Pharm Ther 2014;39: 923–39.
  65. Wright JW , Lovell LA, Gemmell HG , McKiddie F, Staff RT. SeHCAT Retention Values as Measured With a Collimated and an Uncollimated Gamma Camera: A Method Comparison Study. Nucl Med Commun 2013; 34:718-21.